首页> 外国专利> 2-chloro-4-(1h-pyrazol-5-yl)benzonitrile and (s)-4-(1-(2-aminopropyl)-1h-pyrazol-3-yl)-2-chlorobenzonitrile as intermediates in the process for preparing (s)-3-acetyl-n-(1-(3-(3-chloro-4-cyanophenyl)-1h-pyrazol-1-yl)propan-2-yl)-1h-pyrazole-5-carboxamide

2-chloro-4-(1h-pyrazol-5-yl)benzonitrile and (s)-4-(1-(2-aminopropyl)-1h-pyrazol-3-yl)-2-chlorobenzonitrile as intermediates in the process for preparing (s)-3-acetyl-n-(1-(3-(3-chloro-4-cyanophenyl)-1h-pyrazol-1-yl)propan-2-yl)-1h-pyrazole-5-carboxamide

机译:2-氯-4-(1h-吡唑-5-基)苄腈和(s)-4-(1-(2-氨基丙基)-1h-吡唑-3-基)-2-氯苄腈为中间体制备(s)-3-乙酰基-n-(1-(3-(3-氯-3-氰基苯基)-1h-吡唑-1-基)丙烷-2-基)-1h-吡唑-5-羧酰胺

摘要

Compounds of formula (I) wherein R 1 to R 16 , A. B and E are as defined in the claims and pharmaceutically acceptable salts and esters thereof, are disclosed. The compounds of formula (I) possess utility as tissue-selective androgen receptor modulators (SARM) and are particularly useful as medicaments in the treatment of prostate cancer and other AR dependent conditions and diseases where AR antagonism is desired.
机译:公开了其中R 1至R 16,A,B和E如权利要求中所定义的式(I)化合物及其药学上可接受的盐和酯。式(I)的化合物具有用作组织选择性雄激素受体调节剂(SARM)的效用,并且特别可用作治疗前列腺癌和其他需要AR拮抗的AR依赖性疾病和疾病的药物。

著录项

  • 公开/公告号IL238044A

    专利类型

  • 公开/公告日2016-07-31

    原文格式PDF

  • 申请/专利权人 ORION CORPORATION;

    申请/专利号IL20150238044

  • 发明设计人

    申请日2015-03-30

  • 分类号A61K;A61P;C07D;

  • 国家 IL

  • 入库时间 2022-08-21 14:26:02

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号